MedPath

Effect of Robot-assisted Training on Foot Drop in Multiple Sclerosis

Phase 1
Completed
Conditions
MS (Multiple Sclerosis)
Registration Number
NCT00872053
Lead Sponsor
US Department of Veterans Affairs
Brief Summary

The primary aim of this study is to:

1. Collect pilot data on the effect of task-specific lower extremity training using the Anklebot on subjects with Multiple Sclerosis (MS) and who have foot drop;

2. Collect pilot data on the use of combination therapy on improving gait in subjects with MS. This therapy will use both Anklebot training and robot-assisted gait training.

Hypothesis: Both trainings will result in improved walking performance, but the combination therapy will result in greater gains than ankle training alone.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria
  • Clinical diagnosis of MS by McDonald criteria (McDonald, Compston et al. 2001). EDSS level between 3.5-5.5, who report ambulation problems.
  • Presence of unilateral foot drop that is clinically apparent to the PI or PI designate.
  • Must be able to ambulate 25 feet without an assisting device.
Exclusion Criteria
  • Cardiovascular: recent MI < 4 wk, uncontrolled HTN >190/110 mmHg.
  • History of uncontrolled diabetes.
  • Symptoms of orthostasis when standing up.
  • Circulatory problems, history of vascular claudication or pitting edema.
  • Unable to fully understand instructions in order to use the equipment or the process of the study.
  • Body weight over 150 kg.
  • Lower extremity injuries that limit range of motion or function.
  • Joint problems (hip or leg) that limit range of motion or cause pain with movement despite treatment.
  • Unstable fractures.
  • Pressure sores with any skin breakdown in areas in contact with the body harness or Lokomat apparatus.
  • Chronic and ongoing alcohol or drug abuse.
  • Pre-morbid, ongoing depression or psychosis.
  • Ongoing physical therapy.
  • Pregnancy (self-reported)
  • PI's determination of inability to complete the test protocol

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Ankle accuracy and stiffnessAt inclusion, after 8 sessions, after 16 sessions
Secondary Outcome Measures
NameTimeMethod
Gait assessments (e.g., 6-Minute Walk, Timed 25-Foot Walk)At inclusion, after every 4 sessions
Functional assessments (EDSS, MS Functional Composite)At inclusion, after 8 sessions, after 16 sessions

Trial Locations

Locations (1)

Providence VA Medical Center

πŸ‡ΊπŸ‡Έ

Providence, Rhode Island, United States

Providence VA Medical Center
πŸ‡ΊπŸ‡ΈProvidence, Rhode Island, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.